Washington State Community Expedited Partner Treatment (EPT) Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

33,222

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

December 31, 2010

Study Completion Date

August 31, 2011

Conditions
GonorrheaNeisseria GonorrhoeaeChlamydia Trachomatis
Interventions
OTHER

Patient delivered partner therapy

The study will provide communities with access to free PDPT for heterosexuals with gonorrhea or chlamydial infection. PDPT will be packaged to meet the requirements of the WA State Board of Pharmacy and will include 1gram of azithromycin, information about STD, condoms, and information about enclosed medication in English and Spanish. PDPT packs for gonorrhea will also include 400mg of cefixime.

BEHAVIORAL

Targeted public health partner services

During intervention periods, communities will receive public health partner services (PS) provided by Disease Intervention Specialists (DIS). Diagnosing clinicians will triage their patients to receive PS based on defined criteria associated with not ensuring partners' treatment. PS will include an offer to notify partners for each index case. When DIS notify partners they will offer them the opportunity to obtain free medication at a local pharmacy, at a clinic (as available) or through the mail. DIS will also offer to refer partners for complete evaluations insofar as such care is available in local communities.

Trial Locations (2)

98104

University of Washington, Seattle

98504-7890

Washington State Department of Health, Olympia

All Listed Sponsors
collaborator

Washington State, Department of Health

OTHER_GOV

collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

University of Washington

OTHER

NCT01665690 - Washington State Community Expedited Partner Treatment (EPT) Trial | Biotech Hunter | Biotech Hunter